Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More

Luminex® Blog

The Faces of Luminex: Christine Valle, Global Marketing

Here at Luminex, each system we develop has a dedicated team managing every detail of the instruments, reagents, specifications, and more. For our xMAP® Technology, that team is led by Christine Valle, Director of Global Systems & Consumables Marketing. The proud Texas native came to Luminex in 2011 and holds a bachelor’s degree from Sam Houston State University.

Continue Reading >

xMAP® Technology Overview



xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

In the ever-changing regulatory and reimbursement landscape, control and flexibility over #GI, #bloodstream, &…
h J R
We all ❤ the rapid results molecular #GI panels offer, but could use more control over pathogens tested & panel des…
h J R
The Guava easyCyte System is a versatile benchtop platform for additional, multi-dimensional cell health assessment…
h J R

Latest News

March 5
Luminex Corporation to Present at the Barclays Global Healthcare Conference

February 8
Luminex Corporation Declares First Quarter Cash Dividend

February 4
Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results

January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio

November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results


Drug Discovery Summit
11-12 June
Berlin, Germany

UKEV Summer School 2019
16-19 July
Nottingham, UK

3-4 September
Zurich, Switzerland